Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 5:14:895-903.
doi: 10.2147/IDR.S288869. eCollection 2021.

Renal Involvement in COVID-19: A Review of the Literature

Marco Giuseppe Migliaccio #  1 , Marco Di Mauro #  1 , Riccardo Ricciolino  1 , Giorgio Spiniello  1 , Vincenzo Carfora  1 , Nicoletta Verde  1 , Filiberto Fausto Mottola  1 , Nicola Coppola  2 ; Vanvitelli COVID-19 Group
Affiliations
Review

Renal Involvement in COVID-19: A Review of the Literature

Marco Giuseppe Migliaccio et al. Infect Drug Resist. .

Abstract

Kidney injury may be a severe complication of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and contributes to worsen the prognosis. Various pathophysiological mechanisms can contribute to organ damage and impair renal function, proving the complexity of the virus activity and the resulting immunity response. We summarized the evidence of the literature on the prevalence of kidney involvement, on the pathogenic pathways and on its management.

Keywords: COVID-19; SARS-CoV-2; acute kidney injury; kidney injury.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest for this work.

Figures

Figure 1
Figure 1
Pathogenesis of SARS-CoV2.
Figure 2
Figure 2
Sites of direct renal damage in SARS-CoV2.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organisation. Novel coronavirus – China; 2020. Available from: https://coronavirus.jhu.edu/map.html.
    1. Russo A, Minichini C, Starace M, et al. Current status of laboratory diagnosis for covid-19: a narrative review. Infect Drug Resist. 2020;Volume 13:2657–2665. doi:10.2147/IDR.S264020 - DOI - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Macera M, De Angelis G, Sagnelli C, Coppola N. Clinical presentation of covid-19: case series and review of the literature. Int J Environ Res Public Health. 2020;17(14):5062. doi:10.3390/ijerph17145062 - DOI - PMC - PubMed
    1. Carfora V, Spiniello G, Ricciolino R, et al. Anticoagulant treatment in COVID-19: a narrative review. J Thromb Thrombolysis. 2020. doi:10.1007/s11239-020-02242-0 - DOI - PMC - PubMed

LinkOut - more resources